Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells

Naoyuki Akashi1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan

Tomio Umemoto1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanCorrespondence[email protected]
View further author information

Hodaka Yamada2 Division of Endocrinology and Metabolism, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Takayuki Fujiwara3 Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, JapanView further author information

Kei Yamamoto1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Yousuke Taniguchi1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Kenichi Sakakura1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Hiroshi Wada1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Shin-ichi Momomura1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Hideo Fujita1 Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Saitama, JapanView further author information

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.